WaferGen Bio-systems, Inc.·4

May 27, 8:36 PM ET

Shivji Alnoor 4

4 · WaferGen Bio-systems, Inc. · Filed May 27, 2011

Insider Transaction Report

Form 4
Period: 2011-05-25
Shivji Alnoor
DirectorChief Executive Officer10% Owner
Transactions
  • Purchase

    Common Stock Warrant (right to buy)

    2011-05-25+735,493735,493 total(indirect: By Trust)
    Exercise: $0.62Common Stock (735,493 underlying)
  • Purchase

    Convertible Promissory Note due 11/27/2014

    2011-05-25(indirect: By Trust)
    Exercise: $5.70Series A-2 Convertible Preferred Stock (39,447.73 underlying)
  • Purchase

    Series A-1 Convertible Preferred Stock

    2011-05-25+38,461.5438,461.54 total(indirect: By Trust)
    Common Stock (384,615 underlying)
Footnotes (5)
  • [F1]The securities will be convertible into common stock at any time following the closing date on a one-for-ten basis, and have no expiration date.
  • [F2]The reported securities will be purchased by the reporting person for an aggregate purchase price of $400,000.
  • [F3]The securities will be convertible into common stock at any time following the closing date and expire five years thereafter.
  • [F4]The principal amount of the security will be convertible into Series A-2 convertible preferred stock, in whole or in part, at any time following the closing date, from time to time, with no expiration date.
  • [F5]Amount is based on principal amount of the security.

Documents

1 file
  • 4
    v224538_ex.xmlPrimary